Glutathione is a therapeutically researched peptide studied for its effects on skin and hair, anti-aging, anti-inflammatory. Endogenous tripeptide antioxidant (glutamate-cysteine-glycine) supporting liver detox, skin brightening, and anti-aging. Permitted under WADA rules.
Glutathione (GSH) is a tripeptide made of the amino acids glutamate, cysteine, and glycine, and is the body's most abundant intracellular antioxidant. It is found in plants, animals, fungi, and some bacteria and archaea, and prevents damage to important cellular components caused by reactive oxygen species, free radicals, peroxides, lipid peroxides, and heavy metals. Beyond direct radical scavenging, glutathione supports phase-II liver detoxification, regenerates other antioxidants such as vitamins C and E, and maintains cellular redox balance.
Overview
Supplemental glutathione — oral (including liposomal), intravenous, intramuscular, or subcutaneous — is used for antioxidant support, liver health, and dermatological skin-brightening protocols, though oral bioavailability of standard formulations is limited.
Glutathione is permitted under World Anti-Doping Agency (WADA) rules as a substance; only high-volume intravenous infusion is restricted as a method, not glutathione itself.
Mechanism of action
The body's master intracellular antioxidant. Scavenges free radicals and supports liver phase-II detoxification. Regenerates vitamins C and E. Used for liver health, skin brightening, and anti-aging.
Reported effects
Effects reported in the literature and from preclinical models include:
- Glutathione, alongside superoxide dismutase and catalase, modulates mitochondrial reactive-oxygen-species signaling and limits radiation-induced oxidative injury. [3] Preclinical
- Through the SLC7A11-glutathione peroxidase 4 (GPX4) antioxidant axis, glutathione restrains lipid peroxidation and ferroptotic cell death, while glutathione depletion promotes ferroptotic tissue injury. [2][4][5] Preclinical
- Plant metabolites that raise intracellular glutathione levels neutralize reactive oxygen species and protect pancreatic beta-cells from apoptosis. [1] Preclinical
- Red blood cell glutathione buffering limits membrane lipid and protein damage during exercise-induced oxidative stress and restrains hemoglobin auto-oxidation. [7] Preclinical
- N-acetylcysteine acts as a glutathione precursor, replenishing glutathione stores and regulating intracellular redox homeostasis. [8] Preclinical
- Thalamic glutathione was selectively reduced in migraine patients versus healthy controls with good diagnostic performance, making it a candidate biomarker of brain antioxidant capacity. [6] Anecdotal
Evidence grades: FDA approvedApproved (non-US)Phase IIIPhase IIPhase IPreclinicalAnecdotal
Dosage and administration
Oral
- General: 250-500mg daily, taken on an empty stomach (standard oral bioavailability is low)
- Liposomal: 500-1000mg daily (enhanced absorption versus standard oral)
Intravenous
- Antioxidant/skin protocols: 600-1200mg, 1-3 times weekly
Intramuscular
- 200-600mg, 1-3 times weekly
Subcutaneous
- 100-300mg, several times weekly
Cofactor support
- pair with vitamin C and N-acetylcysteine (NAC) to aid synthesis and recycling
Natty status
Glutathione is generally regarded as compatible with the natty designation, particularly when used for therapeutic healing purposes. Opinions vary across natural bodybuilding federations, and athletes who compete should consult the rulebook of their respective sanctioning body.[9]
Research
The peptide has been the subject of 20 studies and reference works collected on this site. Additional bibliography is in § External links below.
Related compounds
Other peptides in this catalogue with overlapping mechanisms or status:
References
- ^ Bioactive plant metabolites with antihyperglycemic properties: prospects for the prevention and treatment of diabetes mellitus. Recent review
- ^ Endothelial ferroptosis in blood-brain barrier dysfunction and neuroinflammation: mechanisms and immune-vascular crosstalk. Recent review
- ^ Targeting mitochondria as a potential therapeutic strategy against radioresistance in cancer. Recent review
- ^ Ferroptosis, lipid metabolism, and genetic regulation in postoperative rehabilitation of elderly hip fractures: from molecular mechanisms to clinical translation. Recent review
- ^ The role of ferroptosis in the pathogenesis and treatment of breast cancer. Recent review
- ^ Selective reduction of thalamic glutathione in migraine in the absence of detectable N-acetylaspartate alterations. Recent review
- ^ Exercise-induced redox modulation of red blood cell function in health and disease: Mechanistic implications for hemoglobin cycling and microvascular regulation. Recent review
- ^ Beyond Antioxidant Activity, Towards Redox Modulation: N-Acetylcysteine (NAC) in Endometriosis and Uterine Leiomyomas. Recent review
- a b World Anti-Doping Agency. (2026). Prohibited List 2026.
External links
- Wikipedia article
- Metabolic Reprogramming in Renal Cell Carcinoma: A Scoping Review with Quantitative Integration of Metabolomic Studies.
- Comprehensive analysis of pathogenic mechanisms of Enterobacter cancerogenus ECL9 in silkworms.
- Ostrich Meat: A Review on Nutritional Properties and Health Benefits.
- Redox-responsive nanomedicine beyond glutathione: harnessing reactive oxygen species and emerging endogenous triggers for precision drug delivery.
- Redox-responsive LNPs for therapeutics delivery.
- Targeting disulfidptosis: from molecular mechanisms to nanotechnology-mediated delivery strategies.
- Biogenic selenium nanoparticles: a multifunctional tool for combating oxidative stress and chronic diseases.
- An Intermediate-Centric View of Cascade Cancer Nanotherapeutics.
- The design of activatable photosensitizers and applications in precision immunomodulation.
- [Research progress on mechanisms and therapeutic potential of active components of TCM in intervening lipid metabolism reprogramming in colorectal cancer].
- Oxidative Stress in Childhood Nephrotic Syndrome: A Narrative Review From Mechanisms to Clinical Implications.
- 1500mg Glutathione — commercial
This page was last updated on August 4, 2026, at 00:36 (UTC).
Research last reviewed on August 4, 2026.
Text is available under the Creative Commons Attribution-ShareAlike License; additional terms may apply.